Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00934 |
| Species: | Homo sapiens |
| Position : | chrX:135959959-135963959 |
| Year: | 2024 |
| Title: | Chromatin conformation capture in the clinic: 4C-seq/HiC distinguishes pathogenic from neutral duplications at the GPR101 locus |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| Disease Name: | -- |
| PMID: | 39272130 |
| MONDO: | |
| Tissue: | Peripheral Blood |
| Tissue Ontology ID: | UBERON:0000178 |
| Cell Source: | PBMCs |
| CVCL ID: | |
| Cell Type: | peripheral blood mononuclear cell |
| Cell Ontology ID: | CL:0000738 |
| Experiment Type: | Chromatin interaction assay |
| High Throughput Method: | Hi-C, 4C-seq |
| Low Throughput Method: | qRT-PCR, and ChIP-qPCR |
| Target gene : | GPR101 |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|